| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥201.7B | ¥133.2B | +51.4% |
| Operating Income | ¥48.4B | ¥17.0B | +184.2% |
| Ordinary Income | ¥51.1B | ¥18.5B | +176.7% |
| Net Income | ¥39.1B | ¥13.5B | +189.9% |
| ROE | 12.5% | 4.8% | - |
FY2026 Q3 cumulative results: Revenue ¥201.7B (YoY +51.4%), Operating Income ¥48.4B (YoY +184.2%), Ordinary Income ¥51.1B (YoY +176.7%), Net Income ¥39.1B (YoY +189.9%). The substantial revenue expansion was primarily driven by the Optical Products Related segment, which grew to ¥127.3B, while Precision Machinery Related segment contributed ¥74.9B. Operating margin improved significantly to 24.0% from prior year, with gross margin maintained at 45.0%. EPS increased to ¥435.50 (YoY +196.9%). The strong profit growth reflects operating leverage from volume expansion, favorable foreign exchange effects contributing ¥1.7B, and improved segment mix. Net income growth outpaced operating income growth due to non-operating gains including FX benefits.
Revenue increased ¥68.5B (YoY +51.4%) to ¥201.7B, driven predominantly by the Optical Products Related segment which expanded ¥58.6B to ¥127.3B and now represents 63.1% of total revenue. Precision Machinery Related segment grew ¥9.9B to ¥74.9B (YoY +15.4%). The acquisition of MG Corporation during the prior fiscal year contributed to the Precision Machinery segment, generating goodwill of ¥497M. External demand strength in optical products combined with increased production capacity utilization drove the top-line expansion.
Gross profit increased ¥38.4B to ¥90.8B, maintaining a gross margin of 45.0%. SG&A expenses rose ¥18.2B to ¥42.4B, representing 21.0% of revenue. The controlled SG&A ratio despite significant revenue growth demonstrates effective fixed cost absorption. Operating income surged ¥31.4B (YoY +184.2%) to ¥48.4B, with operating margin expanding 9.2 percentage points to 24.0%. This margin improvement reflects strong operating leverage, favorable product mix shifts toward higher-margin optical products, and production efficiency gains.
Non-operating income contributed ¥2.7B net, comprising foreign exchange gains of ¥1.7B, interest income of ¥0.4B, and other items. The ¥1.7B FX gain represents 3.5% of operating income and materially enhanced ordinary income. Extraordinary items were minimal with gains of ¥0.1B and losses of ¥0.1B netting to neutral. The tax burden was standard at 23.7% effective rate (¥12.1B tax expense on ¥51.2B pretax income). Net income reached ¥39.1B, an increase of ¥25.6B (YoY +189.9%).
This represents a revenue up/profit up pattern with profit growth significantly outpacing revenue growth, indicating strong operating leverage and margin expansion.
Optical Products Related segment generated revenue of ¥127.3B with operating income of ¥40.3B, achieving a segment margin of 31.6%. This represents the core business with 63.1% revenue share and 83.1% of segment operating profit. Operating income increased ¥25.9B from ¥13.5B in the prior year (YoY +191.9%), demonstrating exceptional profitability improvement driven by volume growth and operational efficiency.
Precision Machinery Related segment recorded revenue of ¥74.9B with operating income of ¥8.2B, yielding a segment margin of 10.9%. Operating income increased ¥4.6B from ¥3.5B prior year (YoY +130.6%). The segment benefited from the MG Corporation acquisition, which added scale and operational synergies. However, the margin gap between segments is substantial at 20.7 percentage points, indicating the Optical Products business commands significantly higher value-add and pricing power. The precision machinery operations face more competitive market dynamics requiring greater capital intensity and lower margin structures.
[Profitability] ROE reached 12.5%, representing strong capital efficiency driven by net profit margin of 19.4% (expanded from 10.1% YoY) and operating margin of 24.0% (expanded from 12.8% YoY). The margin expansion of 11.2 percentage points in operating margin reflects powerful operating leverage and segment mix improvement. Gross margin maintained at 45.0% demonstrates stable pricing power and cost management. [Cash Quality] Cash and deposits totaled ¥151.5B, representing 39.9% of total assets and providing 2.93x coverage of short-term liabilities. Working capital indicators show receivables of ¥62.2B (DSO 113 days), inventories of ¥11.7B finished goods plus ¥19.5B raw materials and ¥14.1B work-in-process totaling ¥45.3B (DIO 149 days), resulting in a cash conversion cycle of 201 days. The extended working capital cycle indicates room for improvement in asset efficiency. [Investment Efficiency] Asset turnover was 0.53x, with total assets of ¥379.4B generating annualized revenue. Property, plant and equipment of ¥83.4B represents 22.0% of total assets, indicating moderate capital intensity. Goodwill of ¥4.5B from acquisitions represents 1.2% of assets. [Financial Health] Equity ratio of 82.6% (¥313.3B equity vs ¥379.4B assets) reflects an exceptionally conservative capital structure with low financial leverage of 1.21x. Current ratio of 529.7% (¥274.2B current assets vs ¥51.8B current liabilities) and quick ratio of 507.2% provide substantial liquidity cushion. Retained earnings grew to ¥134.3B, accumulating ¥32.1B during the nine-month period.
Cash and deposits increased ¥45.6B YoY to ¥151.5B, representing a 43.1% increase that substantially exceeded net income growth rate. The cash accumulation was supported by strong profitability of ¥39.1B net income, though working capital absorption partially offset operating cash generation. Trade receivables increased ¥18.5B to ¥62.2B, reflecting extended customer payment terms or accelerated sales toward quarter-end. Inventories rose ¥11.5B to ¥45.3B (comprising finished goods ¥11.7B, raw materials ¥19.5B, and work-in-process ¥14.1B), indicating production buildup to support anticipated demand or potential supply chain positioning. Trade payables increased ¥5.9B to ¥18.6B, suggesting improved supplier credit utilization though the increase lagged inventory growth. The net working capital buildup of approximately ¥24B (receivables and inventory increases exceeding payables increase) represents significant cash absorption, suggesting operating cash flow conversion was below net income levels. Property, plant and equipment increased ¥16.1B to ¥83.4B, indicating ongoing capital investment to support revenue expansion. The acquisition of MG Corporation contributed goodwill of ¥0.5B and added ¥2.0B to segment assets in Precision Machinery. Net defined benefit liability stands at ¥10.0B, representing a manageable pension obligation relative to equity base. The current ratio of 529.7% and cash coverage of 2.93x short-term liabilities confirm strong financial flexibility to fund operations and growth initiatives despite working capital intensity.
Ordinary income of ¥51.1B compared to operating income of ¥48.4B indicates net non-operating contribution of ¥2.7B, representing 5.6% of operating income and 1.3% of revenue. The primary non-operating items include foreign exchange gains of ¥1.7B (3.5% of operating income), interest income of ¥0.4B, and other income of ¥0.2B, partially offset by non-operating expenses of ¥0.3B. The FX gains are variable and dependent on exchange rate movements, creating volatility risk in ordinary income that may not recur consistently. Comprehensive income of ¥37.8B compared to net income of ¥39.1B reflects negative adjustments of ¥1.3B in foreign currency translation, ¥0.3B in remeasurements of defined benefit plans, partially offset by ¥0.3B securities valuation gains. The divergence between comprehensive and net income indicates unrealized translation losses reducing total equity accumulation. Operating cash flow data was not disclosed for the quarterly period, preventing direct assessment of cash earnings quality through operating CF to net income ratio. However, the working capital buildup of approximately ¥24B (inferred from receivables and inventory increases exceeding payables) suggests operating cash conversion was materially below reported net income, indicating lower near-term earnings quality. The DSO of 113 days and DIO of 149 days both represent extended cycles that delay cash realization. The cash conversion cycle of 201 days implies roughly 6.7 months between cash outlay and collection, creating significant working capital financing requirements that diminish free cash generation despite strong profitability.
Full-year guidance projects revenue of ¥300.0B, operating income of ¥70.0B, ordinary income of ¥72.0B, and EPS of ¥605.10 with annual dividend of ¥60.00. Q3 cumulative results show revenue achievement of 67.2% (¥201.7B vs ¥300.0B target), operating income of 69.2% (¥48.4B vs ¥70.0B target), and ordinary income of 71.0% (¥51.1B vs ¥72.0B target). Against a standard quarterly progression of 75% by Q3, revenue progress of 67.2% is 7.8 percentage points behind, while operating income at 69.2% is 5.8 points behind and ordinary income at 71.0% is 4.0 points behind. This indicates Q4 requires substantial acceleration to achieve full-year targets, with implied Q4 revenue of ¥98.3B (48.7% of cumulative Q3), operating income of ¥21.6B (44.6% of Q3 cumulative), and ordinary income of ¥20.9B (40.9% of Q3 cumulative). The Q4 requirements suggest backend-loaded revenue recognition or seasonal demand patterns. The company revised guidance upward during the quarter and increased dividend forecast, indicating management confidence in achieving targets. Based on full-year net income guidance implied at approximately ¥54.0B (derived from EPS forecast of ¥605.10 on 8,924K shares), Q3 cumulative net income of ¥39.1B represents 72.4% achievement, requiring Q4 net income of approximately ¥14.9B. The forecast notes reference "assumptions based on currently available information and reasonable premises" with cautionary language about variability.
Interim dividend was ¥30.00 per share with year-end dividend forecast of ¥35.00, totaling annual dividend of ¥60.00. Based on Q3 cumulative EPS of ¥435.50 and estimated full-year EPS forecast of ¥605.10, the payout ratio calculates to 9.9% (¥60.00 dividend / ¥605.10 EPS). Against Q3 cumulative EPS, the annualized payout ratio is 13.8%. The conservative payout ratio provides substantial dividend coverage of 10.1x and indicates significant capacity for dividend growth or capital allocation flexibility. Dividend was revised upward during the quarter as disclosed in company announcement dated February 13, 2026, reflecting improved earnings performance and management's commitment to enhanced shareholder returns. No share buyback activity was disclosed. The total return ratio equals the payout ratio at 9.9% as dividends represent the sole form of capital return. With retained earnings of ¥134.3B and strong cash position of ¥151.5B, the company maintains ample financial flexibility to sustain and potentially increase dividends while funding organic and inorganic growth initiatives.
Working capital management deterioration poses significant cash flow risk, with DSO extending to 113 days and DIO to 149 days, resulting in cash conversion cycle of 201 days that absorbs substantial operating cash generation. The ¥24B working capital buildup during Q3 cumulative period indicates receivables collection and inventory management require urgent attention. If the trend persists, free cash flow generation will remain suppressed despite strong profitability, potentially constraining dividend sustainability and growth investment capacity.
Optical Products segment concentration creates revenue and profit vulnerability, with 63.1% of revenue and 83.1% of segment operating profit derived from this single business line. Demand cyclicality, technological disruption, competitive pricing pressure, or customer concentration in optical products would disproportionately impact overall performance. The 31.6% segment margin commands premium pricing but also faces margin compression risk if competitive dynamics intensify.
Foreign exchange volatility represents earnings quality risk, as the ¥1.7B FX gain contributed 3.5% of operating income and 63.0% of non-operating income. The favorable FX environment in Q3 enhanced ordinary income significantly, but adverse currency movements could reverse gains and pressure profit margins. Export revenue exposure and yen depreciation benefits carry inherent volatility that may not sustain at current contribution levels.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE 12.5% substantially exceeds industry median of 5.8% (2025-Q3, n=105) by 6.7 percentage points, ranking in the top quartile for manufacturing sector capital efficiency. Operating margin of 24.0% significantly outperforms industry median of 8.9% by 15.1 percentage points, reflecting superior pricing power and operational efficiency. Net profit margin of 19.4% exceeds industry median of 6.5% by 12.9 percentage points, demonstrating exceptional profitability relative to sector peers.
Financial Health: Equity ratio of 82.6% substantially exceeds industry median of 63.8% (IQR: 49.1%-74.8%) by 18.8 percentage points, indicating conservative financial leverage well above sector norms. Current ratio of 529.7% significantly exceeds industry median of 2.87x, providing exceptional liquidity coverage. Financial leverage of 1.21x is below industry median of 1.53x, reflecting lower debt utilization and conservative capital structure.
Efficiency: Asset turnover of 0.53x is slightly below industry median of 0.56x, indicating moderate room for improvement in asset utilization efficiency. Receivables turnover at 113 DSO substantially exceeds industry median of 85 days (IQR: 69-117 days), representing slower collection. Inventory turnover at 149 days exceeds industry median of 112 days (IQR: 50-163 days), indicating elevated inventory holding. Operating working capital cycle materially exceeds efficient benchmarks, suggesting significant opportunity for working capital optimization.
Growth: Revenue growth of 51.4% YoY substantially exceeds industry median of 2.8% (IQR: -1.5% to 8.8%), placing the company in the top decile for manufacturing sector growth. EPS growth of 196.9% dramatically outperforms typical sector performance, driven by operating leverage and margin expansion.
(Industry: Manufacturing, Comparison: 2025-Q3 period, Source: Proprietary analysis)
Exceptional profitability performance with operating margin of 24.0% and net margin of 19.4% substantially exceeding manufacturing sector medians by 15.1 and 12.9 percentage points respectively, combined with ROE of 12.5% versus sector median of 5.8%, establishes the company as a top-quartile performer in capital efficiency and earnings power. The 51.4% revenue growth and 184.2% operating income growth demonstrate powerful operating leverage as volume expansion drives margin improvement from fixed cost absorption and favorable segment mix toward higher-margin Optical Products business.
Working capital management deterioration represents the primary operational concern requiring management attention, with cash conversion cycle extending to 201 days driven by DSO of 113 days and DIO of 149 days both exceeding sector medians. The approximate ¥24B working capital absorption during the nine-month period indicates operating cash generation significantly trails reported earnings, creating a material gap between accounting profitability and cash realization. Improvements in receivables collection and inventory turnover efficiency would materially enhance free cash flow generation and reinforce earnings quality.
Conservative financial position with 82.6% equity ratio, ¥151.5B cash holdings representing 39.9% of assets, and current ratio of 529.7% provides substantial strategic and financial flexibility to pursue organic growth investments, selective M&A opportunities, and enhanced shareholder returns while maintaining fortress balance sheet. The 9.9% payout ratio offers significant capacity for dividend growth as earnings trajectory continues, with retained earnings accumulation of ¥32.1B in nine months supporting both capital allocation optionality and cushion against potential demand variability.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.